Aug 23, 2017

Antoxerene closes $1.5M for drug discovery in aging

Posted by in categories: biotech/medical, life extension

Antoxerene performs pipeline testing for small molecule drugs that target protein-drug and protein-protein interactions. The platform is based on a patent-pending production technology, which enables manufacturing of impossible to express protein targets in biologically active form, at scale.

Read more

Comments are closed.